The RADIANCE CED Study
NCT: NCT07231757 · RECRUITING
Brief Summary
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
Frequently Asked Questions
What is The RADIANCE CED Study?
The RADIANCE CED Study is a clinical trial registered under NCT07231757. Current status: RECRUITING.
What is the status of NCT07231757?
The current status of NCT07231757 (The RADIANCE CED Study) is: RECRUITING.
When did The RADIANCE CED Study start?
The RADIANCE CED Study started on 2025-11-21.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.